Cite

HARVARD Citation

    Ugocsai, P. et al. (2016). Biomodulatory metronomic therapy induces PET‐negative remission in chemo‐ and brentuximab‐refractory Hodgkin lymphoma. British journal of haematology. pp. 290-293. [Online]. 
  
Back to record